PI3K-IN-27

PI3K-IN-27

• CAS Number: 2742654-38-0
• UNSPSC Description: PI3K-IN-27 is a potent inhibitor of PI3K. PI3K belongs to a large family of lipid signaling kinase that plays key role in cellular process including cell growth, differentiation, migration and apoptosis. PI3K-IN-27 has the potential for the research of hyper-proliferative diseases like cancer and inflammation, or immune and autoimmune diseases (extracted from patent WO2021233227A1, compound 1)[1].
• Target Antigen: PI3K
• Type: Reference compound
• Related Pathways: PI3K/Akt/mTOR
• Applications: COVID-19-immunoregulation
• Field of Research: Cancer; Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/pi3k-in-27.html
• Solubility: 10 mM in DMSO
• Smiles: NC1=C2C(C3=CC(F)=C(C=C3)OC(C)C)=NN(C2=NC=N1)[C@H](C4=C(C5=CC(F)=CC=C5)C(N6C(SC=C6C)=C4)=O)C
• Molecular Weight: 572.63
• References & Citations: [1]Zuwen ZHOU, et al. Compounds as protein kinase inhibitors. Patent WO2021233227A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported